chartexchange

Madrigal Pharmaceuticals, Inc. Investigation Continues: Investors May Contact Kirby McInerney LLP, a Securities Fraud Law Firm, If You Lost Money On Your MDGL Investments

Newsfile | Nov 18, 2026 10:00 AM EST

New York, New York--(Newsfile Corp. - November 18, 2026) - The law firm of Kirby McInerney LLP continues its investigation on behalf of Madrigal Pharmaceuticals, Inc. ("Madrigal" or the "Company") (NASDAQ: MDGL) investors concerning the Company's and/or members of its senior management's possible violation of the federal securities laws and other unlawful business practices. [CONTACT THE FIRM IF YOU SUFFERED A LOSS] What Happened?On November 3, 2026, Madrigal disclosed in its quarterly report on...

Read original article